Starter and refresher of the duties and responsibilities of a QPPV
Webcode 25022052
Dr. Christian M. Moers
Sträter Lawyers, Bonn, GERMANY
Lawyer;
His prime interests are the interdisciplinary challenges of medicinal product law. His focal advisory areas are as follows:
- European and German medicinal product law
- Marketing authorisation law & regulatory affairs
- Pharmacovigilance
- Wholesale trade with medicinal products, distribution of medicinal products
- Manufacture of medicinal products
More information please click here.
Reinhold Schilling
Wörwag Pharma GmbH & Co. KG, Böblingen, GERMANY
Head of Global Pharmacovigilance, EU-QPPV, local QPPV After completing his chemistry degree, Reinhold Schilling began his industrial career in 2011 as a Drug Safety Junior Manager at UCS Pharma. Following several career advancements, he now holds the position of Head of Global Pharmacovigilance, EU-QPPV, and Stufenplanbeauftragter for Wörwag Pharma and AAA-Pharma. His professional strengths include strategic planning, ensuring compliance, risk management, and signal management.
11/02/2025
11/02/2025
09:00 - 17:00 CET
You may dial in 30 min before the session
online
online
Event - 1,290 € plus tax
The fee includes high-quality course material for download, a participation certificate, access to the Learning Space as well as technical support including a test meeting.
Event - 1,290 € plus tax
The fee includes high-quality course material for download, a participation certificate, access to the Learning Space as well as technical support including a test meeting.
Nadja Wolff
Conference Manager
+49 6221 500-696
n.wolff@forum-institut.de
Update your knowledge: Our team of experts provides you with important and practical information about the tasks and responsibilities of an EU-QPPV.
The Qualified Person for Pharmacovigilance (QPPV) is a central role in any pharmaceutical company, with a high level of responsibility and a variety of duties.
This course provides critical and practical information about the duties of a QPPV and the legal basis for their activities.
It will also examine the major issue of liability and discuss the consequences of Brexit for an EU QPPV.
This online course
08:45
09:00
FORUM Institut
09:15
Dr Christian M. Moers
10:15 Coffee break
10:30
Reinhold Schilling
11:30
Reinhold Schilling
12:45 Lunch break
13:30
Reinhold Schilling
14:15
Reinhold Schilling
15:15 Coffee Break
15:30
Dr Christian M. Moers
16:45 Discussions and/or Q&A session
17:00 End of course
of 5 stars of all ratings from 2023
of 5 stars on Trustpilot = good
During our online training "Toxicology and beyond: Safety assessment in drug development" you will build a solid toxicol...
Explore the transformative potential of artificial intelligence in pharmacovigilance. This course provides an in-depth u...
This course familiarises you with regulatory post-approval duties and provides first-hand information on variation submi...
CMC requirements in Latin America with focus Mexico, Brazil, Colombia, Argentina, Chile, and Peru. The seminar (2 half d...
Preclinical drug development: The online training course for preclinical newcomers with a focus on small molecules and b...
In depth training, excellent information provided, prepares for a good theoretical knowledge.
good overview, practical examples, working sessions, individual questions were answered.
lots of practical items and clear message were provided, speakers were engaged and have a lot of know how.
It gave an overall broad overview of task and responsibilities of QPPV/deputy QPPV. Good examples - practical advise - workshop!
Very good training worth our time and money.
very good training for Senior PV managers, QPPV office staff, QPPVs
